Impact of Fish Oil Supplementation in 3rd Trimester of Pregnancy on Maternal and Offspring Health
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The aim of the trial is to investigate the effect of daily supplementation with 2.7 grams of long chain n-3 fatty acids during the third trimester of pregnancy. In 1990, 533 pregnant women, while they were in gestational week 30, were randomized to fish oil supplements providing the mentioned amount of long chain n-3 fatty acids, olive oil supplements, or no supplements; they were asked to take the supplements until delivery. Health outcomes were assessed during pregnancy and delivery. Further, offspring health and development has been examined during the ensuring two decades by making linkages to the rich Danish health and administrative registries, by asking the offspring to complete web-based questionnaires, and by examining the offspring physically.
| Condition | Intervention |
|---|---|
|
Preterm Delivery Atopy Metabolic Syndrome |
Dietary Supplement: Fish oil Dietary Supplement: Olive oil |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor) Primary Purpose: Basic Science |
| Official Title: | Impact of Fish Oil Supplementation in 3rd Trimester of Pregnancy on Maternal and Offspring Health |
- Gestation length [ Time Frame: 1989-1990 (1 year) ] [ Designated as safety issue: Yes ]We assesed impact of fish oil supplementation in pregnancy on timing of spontaneous delivery
| Enrollment: | 533 |
| Study Start Date: | November 1989 |
| Study Completion Date: | May 2011 |
| Primary Completion Date: | December 1990 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Active Comparator: Fish oil supplementation
These women received 4 1-g capsules of fish oil per day providing 2,7 grams long chain n-3 fatty acids per day, from gestation week 30 until delivery
|
Dietary Supplement: Fish oil
4 1-g gelatine capsules per day providing 2,7 grams long chain n-3 fatty acids
Other Name: Pikasol
|
|
Placebo Comparator: Olive oil
These women received 4 1-g capsules with olive oil per day from gestational week 30 until delivery
|
Dietary Supplement: Olive oil
4 1-g gelatine capsules with virgin olive oil
|
|
No Intervention: No oil supplement
These women received no capsules with oil
|
Eligibility| Ages Eligible for Study: | 20 Years to 50 Years |
| Genders Eligible for Study: | Female |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Healthy pregnant women in gestation week 30
Exclusion Criteria:
- Bleeding episodes during pregnancy
Contacts and Locations| Denmark | |
| Aarhus University Hospital | |
| Aarhus, Denmark, DK-8000 | |
| Principal Investigator: | Sjurdur F. Olsen, MD | Statens Serum Institut |
More Information
Additional Information:
Publications:
| Responsible Party: | Sjurdur Frodi Olsen, Statens Serum Institut, Copenhagen, Denmark |
| ClinicalTrials.gov Identifier: | NCT01353807 History of Changes |
| Other Study ID Numbers: | M-AA-20060182, R21AT004603 |
| Study First Received: | April 29, 2011 |
| Last Updated: | July 8, 2011 |
| Health Authority: | Denmark: De Videnskabsetiske Komiteer |
Keywords provided by Centre for Fetal Programming, Denmark:
|
Fish oil Pregnancy RCT Birth weight |
Gestational age Asthma and allergies Metabolic syndrome Obesity |
Additional relevant MeSH terms:
|
Premature Birth Metabolic Syndrome X Obstetric Labor, Premature Obstetric Labor Complications Pregnancy Complications |
Insulin Resistance Hyperinsulinism Glucose Metabolism Disorders Metabolic Diseases |
ClinicalTrials.gov processed this record on June 17, 2013